Kyverna ‘resetting conversation’ with 1-year miv-cel data as autoimmune CAR-T peers hit safety snags Read more

Lilly puts up $100M, plus billions on the backend, to form 5-target deal with China's InnoCare Read more

Enveda reaps $311M series E to feed ambition to become a ‘household name’ Read more

Navid Gholampour

Navid has over a decade of experience in Life Sciences recruitment. He partners with leaders to build patient-focused and innovative organisation